Business Insider

Anuncia Announces Successful First-in-Human Use of the Alivio ReFlow™ Ventricular System for Treatment of Hydrocephalus

LOWELL, Mass., May 22, 2018 /PRNewswire/ -- Anuncia, Inc., a privately-held company focused on better treatment of hydrocephalus and cerebrospinal fluid dysfunctions, announced, today, the successful ...
MD&M East

HeartWare Seeing Solid Growth with its Ventricular Assist System

Approximately one year after the company landed FDA approval for its Ventricular Assist System, the company is boasting significant surge in revenue. In early morning trading on November 7, the ...
Morningstar

Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical’s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided ...

98% of placements using SOLOPASS® 2.0 entered the ventricular system, versus only 10% of freehand placements. 86% of placements using SOLOPASS® 2.0 accurately reached the ipsilateral frontal horn ...
Business Wire

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.
WRBL

Anuncia Medical Inc. Announces Published Data with Promising Clinical Outcomes Using the ReFlow™ Ventricular System In-Line with Hydrocephalus Shunts

SCOTTSDALE, Ariz., May 23, 2023 /PRNewswire/ -- Anuncia Medical Inc. ("Anuncia" or the "Company"), a company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF ...
Seeking Alpha

Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM; “Adagio Medical”, “Adagio” or the “Company”), a leading innovator in catheter ablation technologies, today ...